Notable Upgrades: (AMZN), Google (GOOGL), Facebook (FB), PayPal Holdings (PYPL), Anthera (ANTH)

Analysts at Wedbush are out with a report this morning upgrading shares of Inc. (AMZN) with a ‘Outperform‘ from ‘Neutral‘ rating. The firm raised its price target for the company to $575 from $435. Separately, Cowen upgraded AMZN to ‘Outperform’ from ‘Market Perform,” saying the online retailer has gained traction in a number of retail markets and that it will be the number one U.S. apparel retailer by fiscal 2017.

Google Inc. (GOOGL) was reiterated a ‘Buy’ by Argus analysts on Monday, noting the search giant’s growth has been driven by its ability to accelerate revenue as advertising dollars shift to the internet, as well as by its extraordinary positioning as the search engine leader. The broker raised its price target on the stock to $850 from $675.

Google shares recently lost $6.91 to $666.02. The stock is up more than 17% year-over-year and has gained roughly 28% year-to-date. In the past 52 weeks, shares of Mountain View, California-based company have traded between a low of $486.23 and a high of $668.87.

Google Inc. closed Friday at $672.93. The name has a current market cap of $454.50 billion.

Facebook, Inc. (FB) rating of ‘Buy’ was reiterated today at BTIG Research with a price target increase of $117 from $80 (versus a $94.97 previous close). The broker believes that in the near-to-medium term, Facebook can exceed consensus estimates.

Facebook Inc. Cl A shares are currently priced at 94.99x this year’s forecasted earnings compared to the industry’s 18.01x earnings multiple. Ticker has a forward P/E of 36.99 and t-12 price-to-sales ratio of 19.75. EPS for the same period is $1.03.

Over the past year, shares of Menlo Park, California-based company have traded between a low of $66.16 and a high of $98.18 and are now at $98.12. Shares are up 43.01% year-over-year and 21.73% year-to-date.

Investment analysts at Nomura initiated coverage on shares of PayPal Holdings, Inc. (PYPL) in a note issued to investors on Monday. The firm set a ‘Buy‘ rating and a $46 price target on the stock. The name was also initiated with a ‘Outperform’ at Wells Fargo (WFC).

In a report published Monday, Piper Jaffray analysts raised their Anthera Pharmaceuticals, Inc. (ANTH) price target to $14 from $7.50, implying 32% expected upside from the stock’s current price.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.